К основному контенту

Aldara

Aldara

     * Generic Name: imiquimod
     * Brand Name: Aldara


     * What is imiquimod topical (Aldara, Zyclara, Zyclara Pump)?
     * What are the possible side effects of imiquimod topical
       (Aldara, Zyclara, Zyclara Pump)?
     * What is the most important information I should know about
       imiquimod topical (Aldara, Zyclara, Zyclara Pump)?
     * What should I discuss with my healthcare provider before using
       imiquimod topical (Aldara, Zyclara, Zyclara Pump)?
     * How should I apply imiquimod topical (Aldara, Zyclara, Zyclara
       Pump)?
     * What happens if I miss a dose (Aldara, Zyclara, Zyclara Pump)?
     * What happens if I overdose (Aldara, Zyclara, Zyclara Pump)?
     * What should I avoid while using imiquimod topical (Aldara,
       Zyclara, Zyclara Pump)?
     * What other drugs will affect imiquimod topical (Aldara,
       Zyclara, Zyclara Pump)?
     * Where can I get more information (Aldara, Zyclara, Zyclara
       Pump)?

What is imiquimod topical (Aldara, Zyclara, Zyclara Pump)?

   Imiquimod is an immune response modifier. Imiquimod topical is
   used to treat actinic keratosis (a condition caused by too much sun
   exposure) on the face and scalp.

   Imiquimod topical (for the skin) is also used to treat a minor form of
   skin cancer called superficial basal cell carcinoma, when
   surgery would not be an appropriate treatment.

   Imiquimod topical also treats genital warts that appear on the
   outside of the body, but this medicine is not a cure for genital
   warts. Imiquimod may be used in adults and children who are at least 12
   years.

   Imiquimod topical may also be used for purposes not listed in this
   medication guide.

What are the possible side effects of imiquimod topical (Aldara, Zyclara,
Zyclara Pump)?

   Get emergency medical help if you have any of these signs of an
   allergic reaction: hives; difficulty breathing; swelling of your face,
   lips, tongue, or throat.

   Wash off the medicine and call your doctor at once if you have a
   serious skin reaction such as severe itching, burning, oozing,
   bleeding, or skin changes where the medicine is applied.

   Stop using imiquimod topical and call your doctor at once if you have a
   serious side effect such as flu symptoms such as fever, chills, body
   aches, tired feeling, swollen glands.

   When treating genital warts around the vagina, if you have severe
   swelling or urination problems, stop using imiquimod topical and call
   your doctor right away.

   Less serious side effects may include:
     * mild skin irritation, itching, dryness, flaking, scabbing,
       crusting, redness, or hardening of the skin where the medicine was
       applied;
     * changes in the color of treated skin;
     * headache, dizziness, chest pain, back pain;
     * cold sores, fever blisters;
     * cold symptoms such as stuffy nose, sneezing, sore
       throat;
     * nausea, diarrhea, loss of appetite; or
     * vaginal itching or discharge.

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about imiquimod topical
(Aldara, Zyclara, Zyclara Pump)?

   Using too much of this medicine, or using it for too long can increase
   your risk of severe skin reactions. Follow your doctor's instructions.

   Do not use imiquimod topical on areas of broken, wounded, or burned
   skin. Wait until these conditions have healed before using imiquimod
   topical.

   Before using this medication, tell your doctor if you have a weak
   immune system, an autoimmune disorder, graft-versus-host
   disease, or if you have recently received a bone marrow transplant
   or cord blood transplant.

   When treating genital warts around the vagina, avoid getting the cream
   on the more sensitive inner layers of vaginal tissue. This could result
   in vaginal swelling or irritation and painful urination.

   Avoid exposure to sunlight or tanning beds. Imiquimod topical can make
   you sunburn more easily. Wear protective clothing and use sunscreen
   (SPF 30 or higher) when you are outdoors.

   Imiquimod topical is not a cure for genital warts and it may not keep
   you from spreading this condition to others through vaginal, anal, or
   oral sex. You may develop new lesions during treatment with imiquimod
   topical. For best results, keep using the medicine for the entire
   length of time prescribed by your doctor.

   Imiquimod will not protect against sexually transmitted diseases such
   as chlamydia, gonorrhea, herpes, HIV, syphilis, and
   trichomoniasis.

   If you are treating the genital or rectal area with imiquimod
   topical, avoid sexual activity while the medicine is on your skin.
   Imiquimod topical can weaken the rubber that condoms or diaphragms
   are made out of. If you use a condom or diaphragm for birth
   control, these items could break if the rubber weakens and an unplanned
   pregnancy could result.

   Aldara Patient Information including How Should I Take
   STD Diagnosis, Images, Symptoms, Treatment

   Sexually Transmitted Diseases (STDs) Slideshow Pictures
   Erectile Dysfunction (ED) Causes and Treatment

   Impotence (ED) Slideshow Pictures
   RxList

   Take the Quiz on STDs

What should I discuss with my healthcare provider before using imiquimod
topical (Aldara, Zyclara, Zyclara Pump)?

   To make sure you can safely take imiquimod topical, tell your doctor if
   you have any of these other conditions:
     * sunburn or other skin problems;
     * a weak immune system or autoimmune disorder;
     * graft-versus-host disease;
     * if you have recently been treated for actinic keratosis or
       genital warts with surgery or other medications; or
     * if you have recently received a bone marrow transplant or cord
       blood transplant.

   FDA pregnancy category C. It is not known whether imiquimod topical
   will harm an unborn baby. Tell your doctor if you are pregnant or plan
   to become pregnant while using this medication.

   If you are treating the genital or rectal area with imiquimod topical,
   avoid sexual activity while the medicine is on your skin. Imiquimod
   topical can weaken the rubber that condoms or diaphragms are made out
   of. If you use a condom or diaphragm, these items could break if the
   rubber weakens, and an unplanned pregnancy could result.

   It is not known whether imiquimod topical passes into breast milk or if
   it could harm a nursing baby. Do not use this medication without
   telling your doctor if you are breast-feeding a baby.

   Do not use this medicine on a child younger than 12 years old.
   Imiquimod topical is for use in treating genital warts in patients who
   are at least 12 years old. All other uses of this medication are for
   adults over 18 only.

How should I apply imiquimod topical (Aldara, Zyclara, Zyclara Pump)?

   Use exactly as prescribed by your doctor. Do not use in larger or
   smaller amounts or for longer than recommended. Follow the directions
   on your prescription label.

   Using too much of this medicine, or using it for too long can increase
   your risk of severe skin reactions.

   Before applying imiquimod topical, wash your hands and wash the skin
   area to be treated. Allow the skin to dry for at least 10 minutes
   before applying the medicine. Always wash your hands after applying the
   medicine also.

   Do not use imiquimod topical on areas of broken, wounded, or burned
   skin. Wait until these conditions have healed before using imiquimod
   topical.

   Imiquimod topical is normally used 2 to 5 times per week for up to 16
   weeks. How you use this medication will depend on the condition you are
   treating. Follow your doctor's instructions.

   Actinic keratosis:

   Aldara is usually applied 2 times per week (such as Monday and
   Thursday, or Tuesday and Friday) for a full 16 weeks. Zyclara is
   applied once daily for 2 weeks followed by 2 weeks without treatment.
   Apply the cream to the treatment area in a thin layer, and rub in the
   cream until it disappears. Use the medicine before going to bed and
   leave it on for 8 hours. In the morning, wash off the medicine with
   water and a mild soap.

   Superficial basal cell carcinoma:

   Usually applied 5 times per week (such as Monday through Friday) for a
   full 6 weeks. Apply the cream from one imiquimod topical packet to the
   treatment area and the border of skin around it, and rub in the cream
   until it disappears. Use the medicine before going to bed and leave it
   on for 8 hours. In the morning, wash off the medicine with water and a
   mild soap.

   Genital warts:

   Usually applied 3 times per week (such as Monday, Wednesday, and
   Friday) for no longer than 16 weeks. Apply the cream from one imiquimod
   topical packet to the treatment area, and rub in the cream until it
   disappears. Do not cover the treated skin areas with any type of
   plastic bandaging, and avoid nylon underwear. You may wear
   cotton gauze or underwear over the treated area. Use the medicine
   before going to bed and leave it on for 6 to 10 hours. Then wash off
   the medicine with water and a mild soap.

   When treating genital warts under the foreskin of an uncircumcised
   penis, pull back the foreskin and wash it with mild soap and water
   before applying imiquimod topical. Clean this area daily during
   treatment.

   When treating genital warts around the vagina, avoid getting the cream
   on the more sensitive inner layers of vaginal tissue. This could result
   in vaginal swelling or irritation and painful urination.

   Imiquimod topical is not a cure for genital warts and it may not keep
   you from spreading this condition to others through vaginal, anal, or
   oral sex. You may develop new lesions during treatment with imiquimod
   topical. For best results, keep using the medicine for the entire
   length of time prescribed by your doctor.

   All conditions:

   Your doctor will need to check your skin on a regular basis, especially
   if you have a more severe skin reaction to the medication. Do not miss
   any scheduled appointments.

   Call your doctor if your skin condition does not improve or if it gets
   worse during treatment.

   Do not use imiquimod topical to treat any skin condition that has not
   been checked by a doctor. Do not share this medication with anyone
   else, even if they have the same symptoms you have.

   Each packet of imiquimod topical is for a single application only.
   Throw away the packet after one use, even if there is medicine left in
   it. If you treat more than one skin area at a time, ask your doctor how
   many packets to use.

   Store at room temperature away from moisture and heat. Do not freeze.
   Keep each packet unopened until you are ready to use it.

   Aldara Patient Information including If I Miss a Dose
   STD Diagnosis, Images, Symptoms, Treatment

   Sexually Transmitted Diseases (STDs) Slideshow Pictures
   Erectile Dysfunction (ED) Causes and Treatment

   Impotence (ED) Slideshow Pictures
   RxList

   Take the Quiz on STDs

What happens if I miss a dose (Aldara, Zyclara, Zyclara Pump)?

   Skip the missed dose and wait until the next time you are getting ready
   for bed to use the medicine. Do not use extra medicine to make up the
   missed dose.

What happens if I overdose (Aldara, Zyclara, Zyclara Pump)?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

   Overdose symptoms may include severe skin irritation, feeling
   light-headed, or fainting.

What should I avoid while using imiquimod topical (Aldara, Zyclara, Zyclara
Pump)?

   Avoid getting this medication in your eyes, mouth, and nose, or on your
   lips. Do not place the cream in your rectum, vagina, or
   urethra. If it does get into any of these areas, rinse with water.
   Do not use imiquimod topical on sunburned, windburned, dry, chapped,
   irritated, or broken skin.

   Avoid using other medications on the areas you treat with imiquimod
   topical unless your doctor tells you to.

   Avoid exposure to sunlight or tanning beds. Imiquimod topical can make
   you sunburn more easily. Wear protective clothing and use sunscreen
   (SPF 30 or higher) when you are outdoors.

   Avoid having unprotected sex. Imiquimod is not a cure for genital
   warts, and it will not protect against sexually transmitted diseases
   such as chlamydia, gonorrhea, herpes, HIV, syphilis, and
   trichomoniasis. Talk with your doctor about safe ways to prevent
   transmission during sex.

What other drugs will affect imiquimod topical (Aldara, Zyclara, Zyclara
Pump)?

   It is not likely that other drugs you take orally or inject will have
   an effect on topically applied imiquimod topical. But many drugs can
   interact with each other. Tell your doctor about all medications you
   use. This includes prescription, over-the-counter, vitamin, and herbal
   products. Do not start a new medication without telling your doctor.

Where can I get more information (Aldara, Zyclara, Zyclara Pump)?

   Your pharmacist can provide more information about imiquimod topical.
     __________________________________________________________________


Комментарии

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...